156 related articles for article (PubMed ID: 32732105)
1. Effect of self-administered vaginal dinoprostone on pain perception during copper intrauterine device insertion in parous women: a randomized controlled trial.
Ashour AS; Nabil H; Yosif MF; Hussein M; Mageed A Allah AA; Mahmoud M; Abdou H; Kholaif K; Mohamed Kotb MM; El Sharkawy M; Abdelhakim AM; Ali AS; Nassar SA; Abbassy AH; Ghamry NK; Abdel-Latif AA; Taher A; El Mahy M
Fertil Steril; 2020 Oct; 114(4):861-868. PubMed ID: 32732105
[TBL] [Abstract][Full Text] [Related]
2. Comparative Efficacy of Vaginal Misoprostol vs Vaginal Dinoprostone Administered 3 Hours Prior to Copper T380A Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled Trial.
Ashour ASA; El Sharkawy M; Ali AS; Keshta NHA; Shatat HBAE; El Mahy M
J Pediatr Adolesc Gynecol; 2020 Oct; 33(5):559-565. PubMed ID: 32330638
[TBL] [Abstract][Full Text] [Related]
3. Benefits of Self-administered Vaginal Dinoprostone 12 Hours before Levonorgestrel-releasing Intrauterine Device Insertion in Nulliparous Adolescents and Young Women: A Randomized Controlled Trial.
Samy A; Ali AS; Latif D; Darweesh FF; Ghamry NK; Metwally AA
J Pediatr Adolesc Gynecol; 2020 Aug; 33(4):382-387. PubMed ID: 32113878
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic vaginal dinoprostone administration six hours prior to copper-T380A intrauterine device insertion in nulliparous women: A randomized controlled trial.
Samy A; Kasem MFY; El Lithy A; Ibrahim AM; El Mahy M; Hussein AH; A-Wahab H; Hussien AH; Allah AAMA; El Din Wali AA; Soliman HH; Masoud AT; Abdou H; Hussein M; Abdella RM; Mostafa M; Zaki SS
Contraception; 2020 Mar; 101(3):162-166. PubMed ID: 31811839
[TBL] [Abstract][Full Text] [Related]
5. Effect of cervical lidocaine-prilocaine cream on pain perception during copper T380A intrauterine device insertion among parous women: A randomized double-blind controlled trial.
Abbas AM; Abdellah MS; Khalaf M; Bahloul M; Abdellah NH; Ali MK; Abdelmagied AM
Contraception; 2017 Mar; 95(3):251-256. PubMed ID: 27823944
[TBL] [Abstract][Full Text] [Related]
6. A randomized double blinded clinical trial to explore the clinical outcomes of vaginal isonicotinic acid hydrazide (INH) administration six hours prior to T380A intrauterine device insertion in persons delivered only by cesarean delivery.
Shady NW; Farouk HA; Sallam HF
Contraception; 2023 Apr; 120():109788. PubMed ID: 35183498
[TBL] [Abstract][Full Text] [Related]
7. Effect of topical glyceryl trinitrate cream on pain perception during intrauterine device insertion in multiparous women: A randomized double-blinded placebo-controlled study.
Abbas AM; Ragab E; Abd Ellah NH; Sabra A; Ali SS; Mohamed A; Yosef AH
J Gynecol Obstet Hum Reprod; 2019 Nov; 48(9):715-718. PubMed ID: 30898632
[TBL] [Abstract][Full Text] [Related]
8. Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion. A randomized, double-blinded, placebo-controlled study.
Fouda UM; Salah Eldin NM; Elsetohy KA; Tolba HA; Shaban MM; Sobh SM
Contraception; 2016 Jun; 93(6):513-8. PubMed ID: 26852833
[TBL] [Abstract][Full Text] [Related]
9. Self-administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial.
Swenson C; Turok DK; Ward K; Jacobson JC; Dermish A
Obstet Gynecol; 2012 Aug; 120(2 Pt 1):341-7. PubMed ID: 22825094
[TBL] [Abstract][Full Text] [Related]
10. Self-administrated vaginal 2% lidocaine in-situ gel for pain relief during copper intrauterine device insertion in women with previous caesarean delivery only: a randomised, double-blind placebo-controlled trial.
Abbas AM; Abd Ellah NH; Hosny MA; Abdellah MS; Ali MK
Eur J Contracept Reprod Health Care; 2021 Apr; 26(2):132-138. PubMed ID: 33539256
[TBL] [Abstract][Full Text] [Related]
11. Vaginal dinoprostone versus placebo for pain relief during intrauterine device insertion: a systematic review and meta-analysis of randomised controlled trials.
Abu-Zaid A; Alshahrani MS; Albezrah NA; Miski NT; Abuzaid M; Aboudi SA; Baredwan A; Almadhi N; Baradwan A; Alomar O; Salem H; A Al-Badawi I; Baradwan S
Eur J Contracept Reprod Health Care; 2021 Oct; 26(5):357-366. PubMed ID: 33691549
[TBL] [Abstract][Full Text] [Related]
12. Vaginal misoprostol prior to intrauterine device insertion in women delivered only by elective cesarean section: a randomized double-blind clinical trial.
Abdellah MS; Abbas AM; Hegazy AM; El-Nashar IM
Contraception; 2017 Jun; 95(6):538-543. PubMed ID: 28088498
[TBL] [Abstract][Full Text] [Related]
13. Self-Administered Lidocaine Gel for Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled Trial.
Rapkin RB; Achilles SL; Schwarz EB; Meyn L; Cremer M; Boraas CM; Chen BA
Obstet Gynecol; 2016 Sep; 128(3):621-8. PubMed ID: 27500351
[TBL] [Abstract][Full Text] [Related]
14. Vaginal misoprostol before copper IUD insertion after previous insertion failure: a double-blind, placebo-controlled, parallel-group, randomised clinical trial.
Rasheedy R; Tamara TF; Allam IS; Abbas AM; Essam El-Din Abd El Salam N; Ferhad Ahmed A
Eur J Contracept Reprod Health Care; 2019 Jun; 24(3):222-226. PubMed ID: 31112079
[No Abstract] [Full Text] [Related]
15. Benefits of vaginal dinoprostone administration prior to levonorgestrel-releasing intrauterine system insertion in women delivered only by elective cesarean section: a randomized double-blinded clinical trial.
Samy A; Abdelhakim AM; Latif D; Hamza M; Osman OM; Metwally AA
Arch Gynecol Obstet; 2020 Jun; 301(6):1463-1471. PubMed ID: 32314015
[TBL] [Abstract][Full Text] [Related]
16. Self-administered vaginal lidocaine gel for pain management with intrauterine device insertion: a blinded, randomized controlled trial.
Conti JA; Lerma K; Schneyer RJ; Hastings CV; Blumenthal PD; Shaw KA
Am J Obstet Gynecol; 2019 Feb; 220(2):177.e1-177.e7. PubMed ID: 30444982
[TBL] [Abstract][Full Text] [Related]
17. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
18. Intrauterine mepivacaine instillation for pain relief during intrauterine device insertion in nulliparous women: a double-blind, randomized, controlled trial.
Envall N; Lagercrantz HG; Sunesson J; Kopp Kallner H
Contraception; 2019 Jun; 99(6):335-339. PubMed ID: 30831101
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial.
Bednarek PH; Creinin MD; Reeves MF; Cwiak C; Espey E; Jensen JT;
Contraception; 2015 Mar; 91(3):193-7. PubMed ID: 25487172
[TBL] [Abstract][Full Text] [Related]
20. Higher dose cervical 2% lidocaine gel for IUD insertion: a randomized controlled trial.
Allen RH; Raker C; Goyal V
Contraception; 2013 Dec; 88(6):730-6. PubMed ID: 24012096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
